Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals

Autor: Gao-Xiang Sun, Enyu Dai, Hong Ling, Xi Chen, Di Li, Xiao-Yu He, Donghai Li, Yanhong Liu, Chen-Yu Zhang, Jin Fu, Jia-Yi Cui, Hongwei Liang, Chihao Zhao, Xin-Ling Pan, Na Jiao, Ke Zen, Chun-Lei Zhang, Fengmin Zhang
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Bacterial Diseases
Physiology
Molecular biology
Extensively Drug-Resistant Tuberculosis
lcsh:Medicine
Biochemistry
0302 clinical medicine
Sequencing techniques
Blood plasma
Tuberculosis
Multidrug-Resistant

Medicine and Health Sciences
lcsh:Science
Multidisciplinary
biology
Reverse Transcriptase Polymerase Chain Reaction
RNA sequencing
Middle Aged
Body Fluids
Nucleic acids
Actinobacteria
Infectious Diseases
Blood
030220 oncology & carcinogenesis
Healthy individuals
Biomarker (medicine)
Female
Anatomy
Research Article
Adult
Tuberculosis
Adolescent
Blood Plasma
Mycobacterium tuberculosis
03 medical and health sciences
Extraction techniques
Pulmonary tuberculosis
microRNA
medicine
Genetics
Humans
Non-coding RNA
Tuberculosis
Pulmonary

Biology and life sciences
Bacteria
business.industry
lcsh:R
Organisms
Extensively drug-resistant tuberculosis
medicine.disease
biology.organism_classification
Tropical Diseases
RNA extraction
Gene regulation
Research and analysis methods
MicroRNAs
030104 developmental biology
Molecular biology techniques
Immunology
RNA
lcsh:Q
Gene expression
business
Biomarkers
Mycobacterium Tuberculosis
Zdroj: PLoS ONE
PLoS ONE, Vol 12, Iss 9, p e0184113 (2017)
ISSN: 1932-6203
Popis: Cavities are important in clinical diagnosis of pulmonary tuberculosis (TB) infected by Mycobacterium tuberculosis. Although microRNAs (miRNAs) play a vital role in the regulation of inflammation, the relation between plasma miRNA and pulmonary tuberculosis with cavity remains unknown. In this study, plasma samples were derived from 89 cavitary pulmonary tuberculosis (CP-TB) patients, 89 non-cavitary pulmonary tuberculosis (NCP-TB) patients and 95 healthy controls. Groups were matched for age and gender. In the screening phase, Illumina high-throughput sequencing technology was employed to analyze miRNA profiles in plasma samples pooled from CP-TB patients, NCP-TB patients and healthy controls. During the training and verification phases, quantitative RT-PCR (qRT-PCR) was conducted to verify the differential expression of selected miRNAs among groups. Illumina high-throughput sequencing identified 29 differentially expressed plasma miRNAs in TB patients when compared to healthy controls. Furthermore, qRT-PCR analysis validated miR-769-5p, miR-320a and miR-22-3p as miRNAs that were differently present between TB patients and healthy controls. ROC curve analysis revealed that the potential of these 3 miRNAs to distinguish TB patients from healthy controls was high, with the area under the ROC curve (AUC) ranged from 0.692 to 0.970. Moreover, miR-320a levels were decreased in drug-resistant TB patients than pan-susceptible TB patients (AUC = 0.882). In conclusion, we identified miR-769-5p, miR-320a and miR-22-3p as potential blood-based biomarkers for TB. In addition, miR-320a may represent a biomarker for drug-resistant TB.
Databáze: OpenAIRE